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Purpose: Retinal detachment leads to the widespread cellular remodeling of the retina. The purpose of this study was to
identify protein changes that accompany these cellular alterations by comparing the proteomic profiles of sham and
experimentally detached rabbit retina. Elucidation of the proteins most dramatically affected by retinal detachment would
add further understanding to the pathophysiology of this condition, and potentially identify therapeutic targets useful in
preventing the deleterious effects of detachment, including photoreceptor cell death and the activation of non-neuronal
microglial and Müller cells.
Methods: Retinal detachments were induced in the right eyes of six New Zealand Red pigmented rabbits. Sham surgery
was performed in the right eyes of six other rabbits that were used as controls. At seven days, the eyes were enucleated
and the retinal tissue was harvested. The individual retinal samples were subjected to high resolution two-dimensional
polyacrylamide gel electrophoresis. Differentially expressed protein spots were processed for identification by liquid
chromatography-tandem  mass  spectrometry.  Further  investigation  was  undertaken  with  western  blotting,  and
immunocytochemical studies on a further set of four sham and four detached retinas.
Results: Eighteen protein spots were found to be at least twofold differentially expressed between the sham and detached
retinas. These protein spots were identified as: vimentin; tubulin β-2C; fragments of α-enolase; fructose-bisphosphate
aldolase A; ATP synthase subunit β; mitochondrial creatine kinase; N-terminal fragments of albumin; prohibitin; and
transducin-β1.
Conclusions: The differentially expressed proteins determined in this study may play an important role in the cellular
responses of the retina after its detachment, subsequent ability to recover following surgical reattachment, as well as in
serious complications such as subretinal fibrosis and proliferative vitreoretinopathy.
There  has  been  great  advancement  in  the  practice  of
retinal surgery since Jules Gonin’s pioneering work on retinal
detachment repair from the early twentieth century [1]. Today,
anatomical reattachment of the neurosensory retina following
rhegmatogenous retinal detachment is successfully achieved
in approximately 90% of cases following primary surgery
[2]. However, proliferative vitreoretinopathy (PVR), which is
estimated to occur in 5–10% of cases of rhegmatogenous
retinal  detachment,  remains  the  main  cause  of  failed
reattachment surgery [3-6]. PVR is an unwelcome wound
healing process of the retina, which is characterized by the
proliferation of numerous cell types, including retinal pigment
epithelial (RPE) cells, Müller cells, astrocytes, immune cells,
and hyalocytes that result in the formation of retinal and vitreal
cicatricial membranes. Rhegmatogenous retinal detachment
results  in  the  loss  of  the  close  intercellular  relationship
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between  the  photoreceptors  and  RPE  cells,  and  their
consequent  exposure  to  the  vitreous.  RPE  cells  are  thus
induced to proliferate and migrate into the subretinal space
and  vitreous  cavity  where  they  are  postulated  to  undergo
epithelial-to-mesenchymal  transition  with  an  ability  for
extracellular matrix (ECM) production and contractility [5,
7-11].  The  membranes  formed  from  the  proliferation  and
growth of hypertrophied Müller cells into the subretinal space
and vitreous act as a scaffold on which other cells can migrate,
proliferate, and synthesize ECM constituents, and also offer
support for the growth of neurites originating from horizontal
and  ganglion  cells  [5,12-17].  The  presence  of  subretinal
scarring  can  hinder  the  reestablishment  of  the  interface
between the photoreceptors and RPE, preventing the recovery
of vision after surgical reattachment [18], while contraction
of periretinal membranes can apply deleterious tension on the
retina,  causing  retinal  folding,  the  opening  of  old  retinal
breaks, and the formation of new ones, which may result in
tractional retinal detachment [3,19,20].
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2634Despite the elucidation of the role of numerous cells and
growth factors involved in the pathogenesis of PVR, there is
presently no effective pharmacological agent for the treatment
of this condition in patients [3,21-25].
In an effort to further understand the biochemical and
cellular  remodelling  processes  occurring  in  retinal
detachment, subretinal fibrosis and PVR, with the ultimate
goal of finding novel biomarkers and therapeutic targets we
performed the first proteomic analysis of the retina in an
animal  model  of  this  condition,  whose  well  characterized
retinal  changes  [26,27]  have  been  shown  to  share  many
features with the human form of the disease [28-31]. Indeed,
it is the proteins as the effectors of gene expression that will
ultimately determine the pathophysiological changes in the
retina following detachment and its ability to functionally
recover following surgical reattachment [32].
METHODS
Retinal detachment surgery: Six New Zealand Red pigmented
rabbits were anesthetized using an intramuscular injection of
xylazine and ketamine (6.7 and 33.3 mg/kg, respectively). The
pupils  were  dilated  with  topical  drops  of  atropine  and
tropicamide  (1%  solutions).  A  fine  custom-pulled  glass
micropipette with a tip diameter of approximately 100 µm was
connected via tubing to a 10 ml syringe attached to an infusion
pump. The syringe contained a solution of sodium hyaluronate
(Healon, 0.25% in a balanced salt solution; Pharmacia, NJ).
Using an ophthalmic operating microscope, the pipette, which
was attached to a micromanipulator, was carefully advanced
through an incision in the sclera and pars plana of the right
eye, avoiding the lens. A corneal contact lens was used to
better visualize the interior of the eye. As soon as the pipette
tip was observed touching the retina, the infusion pump was
activated under the control of a foot pedal, which started an
infusion of Healon solution into the subretinal space. Healon
was necessary to prevent spontaneous retinal reattachment.
After approximately 50% of the inferior neural retina was
detached, the pipette was withdrawn and the scleral incision
was closed with an 8–0 nylon suture. Sham surgery, which
involved making the scleral incision and inserting the pipette
into the vitreous cavity without disruption of the retina, was
performed in the right eyes of six other rabbits that were used
as  controls.  No  signs  of  raised  intraocular  pressure  (e.g.,
hardness of the eye, inflammation) were noted during or after
the surgical procedures. Seven days after the surgery, the
twelve rabbits were euthanized with Euthasol (120 mg/kg;
Butler Schein, Dublin, OH), the eyes were enucleated, and the
corneas and lenses were removed. Thereafter, the inferior
detached and sham retinas were peeled from the underlying
RPE in the respective eyes and were immediately snap frozen
in liquid nitrogen within separate vials. Particular care was
taken  to  avoid  contamination  of  the  neurosensory  retina
samples with RPE cells, choroid or vitreous. The samples
were stored at −80 °C until further use.
The  animal  experiments  undertaken  in  this  study
conformed to the National Institutes of Health Animal Care
and Use Committee protocols, the ARVO statement for the
Use of Animals in Ophthalmic and Vision Research, and the
guidelines  of  the  Animal  Resource  Centre,  University  of
California, Santa Barbara.
Protein  extraction:  Retinal  tissue  was  homogenized  and
dissolved in a lysis buffer containing 9 M urea, 2% (v/v) Triton
X-100, 2% (v/v) immobilized pH gradient (IPG) buffer (pH
3–10 nonlinear), and 2% (w/v) dithiothreitol (DTT). The total
protein content in each retinal sample was determined with
the Non-Interfering Protein Assay (Calbiochem, San Diego,
CA). The extracted protein samples were stored at −80 °C.
Two-dimensional  gel  electrophoresis:  The  first  dimension
isoelectric  focusing  (IEF)  was  performed  using  pH  3–10
nonlinear  18  cm  IPG  strips  (GE  Healthcare,  Chalfont  St.
Giles, Buckinghamshire, UK). Each IPG strip was rehydrated
for 20 h at room temperature in 200 µl lysis buffer each
containing 40 µg protein from individual retinal samples, and
150  µl  rehydration  buffer  (8  M  urea,  2%  (w/v)  3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulphonate
(CHAPS), 0.3% (w/v) DTT and 2% (v/v) IPG buffer), using
the Immobiline DryStrip Reswelling Tray (GE Healthcare).
IEF was performed on a Multiphor II Electrophoresis System
(GE Healthcare) at 500 V for 5 h, 3500 V for 5 h, and 3500 V
for 9.5 h in a gradient mode at 17 °C using a MultiTemp III
Thermostatic Circulator (GE Healthcare). Prior to the second
dimension sodium dodecyl sulfate (SDS) Polyacrylamide gel
electrophoresis  (PAGE),  the  IPG  strips  were  equilibrated
twice; first for 10 min under gentle agitation in 20 ml of
equilibration buffer (0.6% (w/v) Tris-HCl, pH 6.8, 6 M urea,
30% (v/v) glycerol, 1% (w/v) SDS, and 0.05% (w/v) DTT);
second using, 4.5% (w/v) iodoacetamide and bromophenol
blue. For the second dimension, the equilibrated IPG strips
were transferred to 12% polyacrylamide gels. Electrophoresis
was then performed vertically at a maximum voltage of 50 V
for approximately 20 h.
Protein staining: The proteins in the gels were visualized by
silver  staining  optimized  for  high  sensitivity  protein
identification by mass spectrometry [33]. Briefly, individual
gels were fixed overnight in 50% (v/v) ethanol, 12% (v/v)
acetic  acid,  and  0.0185%  (v/v)  formaldehyde.  Following
washing  3  times  for  20  min  in  35%  (v/v)  ethanol  and
pretreatment for 1 min in 0.02% (w/v) Na2S2O3.5H2O, the gels
were rinsed in water and stained in 0.2% (w/v) AgNO3, and
0.028% (v/v) formaldehyde for 20 min. Further rinsing with
water  was  performed  before  development  in  6%  (w/v)
Na2CO3, 0.0185% (v/v) formaldehyde, and 0.0004% (w/v)
Na2S2O3.5H2O,  for  approximately  3  min.  Finally,
development was arrested in a fixative solution of 40% (v/v)
ethanol and 12% (v/v) acetic acid.
Image analysis: Dried silver-stained gels were scanned in a
transmission  mode  using  a  GS-710  Calibrated  Imaging
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were  analyzed  using  PDQuest  (Bio-Rad)  software,  which
designated a volume to each spot proportional to the amount
of protein. All well separated and clearly focused spots that
were  differentially  expressed  at  least  2.0-fold  (Mann–
Whitney U test, p<0.05), between the sham and detached
retina  groups  were  selected  for  identification  by  liquid
chromatography-tandem mass spectrometry (LC-MS/MS).
Protein identification: The proteins were excised from the
gels,  subjected  to  in-gel  tryptic  digestion  and  the  peptide
samples  were  analyzed  by  LC-MS/MS  as  previously
described [34]. In short, digested peptides were separated on
an inert nano LC system (LC Packings, San Francisco, CA)
connected to a Q-Tof Premier mass spectrometer (Waters,
Milford, MA). Spectra were obtained using MassLynx 4 SP4
(Waters).  Raw  data  were  processed  using  ProteinLynx
GlobalServer 2.1 (Waters). The processed data were used to
search the total part of the Swiss-Prot database using the
online version of the Mascot MS/MS Ions Search facility
(Matrix Science, Ltd.) [35]. Searching was performed with
doubly  and  triply  charged  ions  with  up  to  two  missed
cleavages,  a  peptide  tolerance  of  50  ppm,  one  variable
modification, Carbamidomethyl-C, and a MS/MS tolerance
of 0.05 Da. Contaminating peptides such as keratin, trypsin,
bovine serum albumin, and all peptides from previous samples
were disregarded. At least one ‘bold red’ peptide was required
in  the  search.  Individual  peptide  ions  scores  above
approximately 36 indicated identity or extensive homology,
giving a less than 5% probability that the observed match was
a random event. All mass spectra were manually verified.
Western blotting: Twenty micrograms of protein from each
retinal sample was loaded and separated upon Novex 10%–
20% gradient Tris-Glycine polyacrylamide gels (Invitrogen
Corporation, Carlsbad, CA). After transfer by electro-elution
to  nitrocellulose  Hybond-C  Extra  membranes,  blots  were
blocked  overnight  with  5%  skimmed  milk  in  80  mM
Na2HPO4,  20  mM  NaH2PO4,  100  mM  NaCl,  and  0.05%
Tween-20  (PBST),  pH  7.5,  and  this  was  followed  by
incubation with the appropriate primary antibodies (Table 1).
After  washing,  the  membranes  were  incubated  with  the
appropriate  horseradish  peroxidase  (HRP)-conjugated
secondary  antibodies:  P0260  mouse  (1:1000),  P0449  goat
(1:2000),  and  P0163  sheep  (1:1000;  DAKO,  Glostrup,
Denmark).  Proteins  were  visualized  using  the  enhanced
chemiluminescence system (GE Healthcare), with an imaging
system  (Fujifilm  LAS-3000;  Tokyo,  Japan),  and  were
quantified  with  the  integrated  Multi  Gauge  software
(Fujifilm).
Immunocytochemistry:  Four  additional  New  Zealand  Red
pigmented rabbits underwent retinal detachment induction
while four others underwent sham surgery as described above.
The eyes were fixed in 4% paraformaldehyde for a minimum
of 24 h. Four detached and four sham inferior retinal pieces
of approximately 4 mm2 were embedded in 5% low-melt
agarose, sectioned at 100 µm using a vibratome, and were
placed in plastic micro-beakers for the antibody processing.
They were first incubated for 24 h in normal donkey serum
(1:20) in PBS, 0.5% BSA, 0.1% Triton X-100, and 0.1% azide
(PBTA) after which they were incubated (for 24 h) in the
primary antibodies that were verified at the correct molecular
mass  on  western  blotting  (Table  1).  Following  rinsing  in
PBTA (3×5 min, 1×1 h rinsing steps), appropriate secondary
antibodies  for  mouse,  goat,  chicken,  and  sheep  (1:200  in
PBTA; Jackson ImmunoResearch, West Grove, PA) were
applied for 24 h. Control experiments were performed using
isotype antibodies in place of the primary antibodies, followed
TABLE 1. PRIMARY ANTIBODIES USED IN THIS STUDY ALONG WITH THEIR SOURCE AND DILUTIONS.
Antibody Clonality/Immunogen Species and
antibody class
Manufacturer WB
dilution
ICC
antibody
dilution
Tubulin β2 Monoclonal/human C-terminus peptide Mouse IgG Abcam, UK ND 1:100
α-enolase Monoclonal/recombinant full length human
protein
Mouse IgG Abcam, UK 1:2000 1:100
ATP synthase subunit β Monoclonal/whole human heart mitochondria Mouse IgG Abcam, UK 1:2000 1:100
Albumin Polyclonal/rabbit serum albumin Sheep IgG Genway Biotech, Inc., CA 1:5000 1:100
Vimentin Polyclonal/recombinant full length hamster
protein
Chicken IgY Millipore, MA ND 1:2000
Prohibitin Monoclonal/recombinant full length human
protein
Mouse IgG Abcam, UK NAR ND
Creatine kinase,
mitochondrial
Polyclonal/human C-terminus peptide Goat IgG Santa Cruz Biotech, Inc., CA NAR ND
Aldolase A Polyclonal/rabbit muscle aldolase Goat IgG Abcam, UK NAR ND
G-protein β1 Polyclonal/human internal region peptide Goat IgG Santa Cruz Biotech, Inc., CA NAR ND
Isotype control Polyclonal Mouse IgG Abcam, UK ND 1:100
Isotype control Polyclonal Sheep IgG Abcam, UK ND 1:100
Isotype control Polyclonal Chicken IgY Abcam, UK ND 1:100
Isotype control Polyclonal Goat IgG Abcam, UK ND 1:100
         Abbreviations: WB represents western blotting; ICC represents immunocytochemistry; NAR represents no adequate/specific
         reaction; ND represents not determined.
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 antibodyby the appropriate secondary antibodies (Table 1). Controls
were also undertaken by omitting the primary antibodies and
using the appropriate secondary antibodies alone. Sections
were further rinsed, mounted on glass slides, and viewed using
a laser scanning confocal microscope (Olympus FluoView
1000; Center Valley, PA). The resulting images represented
a projection of five z-planes, which were collected at 0.5 µm
intervals. Experimental detachment and sham retinas were
viewed  during  the  same  imaging  session  with  constant
intensity and black level settings on the microscope.
RESULTS
Differential protein expression profiles of sham and detached
neural retina: Up to approximately 800 protein spots were
clearly  resolved  by  two-dimensional  PAGE  (2D-PAGE;
Figure 1). The overall protein expression profiles of the twelve
retinas were quite similar. Eighteen protein spots were found
to be at least twofold differentially expressed between the
sham  and  detached  retinas.  Nine  protein  spots  were
upregulated and nine were downregulated in the detached
retina  group.  Fifteen  of  the  eighteen  protein  spots  were
successfully identified using tandem mass spectrometry, as
given  in  Table  2  and  Appendix  1.  Three  spots  eluded
identification despite repeat processing. The nine upregulated
spots were identified as: vimentin (spot 0502); fragments of
α-enolase (spots 1102, 1204, 2102, and 2204); N-terminal
fragments  of  albumin  (spots  3102,  3105,  and  3502);  and
prohibitin (spot 3301). Of the nine downregulated spots, we
identified 1305 as transducin-β1; 1605 as tubulin β-2C; 1606
as ATP synthase subunit β; 8502 and 8503 as creatine kinase;
and 9401 as fructose-bisphosphate aldolase A. Spots 5101,
5703, and 8605 could not be identified (Table 2).
Immunological  verification  of  the  differential  protein
expression:  The  upregulation  of  vimentin  and  overall
downregulation of tubulin β-2C (though increased expression
within  the  remaining  inner  retina)  following  retinal
detachment  is  in  accordance  with  previous  observations
obtained by western blotting and immunocytochemistry [12,
36],  thereby  confirming  the  validity  of  the  current
methodological approaches.
Among the upregulated proteins, the molecular mass of
vimentin (spot 0502) and prohibitin (spot 3301) as observed
from the 2D-PAGE analysis are in reasonable agreement with
the theoretical mass, suggesting that they are not fragments
(Table 2). Three spots (3102, 3105, and 3502) were found to
be  N-terminal  fragments  of  albumin.  The  approximate
molecular mass of these fragments were between 25 kDa and
45 kDa. The presence of several fragments of albumin was
verified  by  western  blotting  using  a  polyclonal  antibody
(Figure 2). The anti-albumin antibody recognizes a strong
uncleaved albumin band together with several fragments of
lower intensity and lower molecular mass. Judging by the
approximate molecular mass, some of the weaker bands on
the western blot correspond to the 2D-PAGE identified spots.
An analogous pattern was found with α-enolase, which was
detected as fragments in four spots (1102, 1204, 2102, and
2204) with molecular mass between 25 and 30 kDa on the 2D-
PAGE analysis. This pattern is in accordance with a western
blot  analysis,  revealing  relatively  strong  bands  at
approximately  40  kDa  and  50  kDa,  together  with  several
weaker bands between 25 kDa and 50 kDa (Figure 2). As with
albumin, some of the weaker bands on the α-enolase western
blot may correspond with the spots identified by 2D-PAGE.
Among  the  downregulated  spots  we  identified  five
proteins with observed molecular mass that are in reasonable
agreement with their theoretical molecular mass (Table 2).
Thus, these proteins do not seem to be fragments. We used a
specific  antibody  against  ATP  synthase  subunit  β,  which
resulted in a western blot with reasonably strong distinct bands
that were quantifiable (Figure 3). Quantification of the bands
Figure 1. 2D-PAGE analysis of the rabbit retina. Eighteen protein spots were found to be significantly and at least twofold differentially
expressed between the sham (A) and detached retina (B). The gels are representative of the two groups.
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downregulated in detached retina (Figure 3).
We further analyzed the expression pattern of selected
proteins in the retina by immunocytochemistry as shown in
Figure 4 and Figure 5. Vimentin was labeled in the Müller
cells extending from the inner limiting membrane to the outer
limiting membrane of the sham retina (Figure 4A,C,E,G). In
detached retina, the Müller cell hypertrophy is accompanied
by an increased expression of intracellular vimentin and more
labeling into the outer retina (Figure 4B,D,F,H).
Labeling of sham retina reflected cytoskeletal tubulin
β-2C.  We  found  strong  labeling  of  ganglion,  Müller  and
horizontal cells, and of ganglion cell dendritic processes in the
inner plexiform layer (IPL). Weaker labeling was found in the
inner  nuclear  layer  (INL)  and  outer  nuclear  layer  (ONL;
Figure 4A, Figure 5A). In the detached retina, we observed a
dramatic increase in tubulin β-2C staining within the inner
retina and Müller cells (Figure 4B, Figure 5B). Loss of the
photoreceptor cell layer after detachment is likely to account
for the overall decrease in tubulin β-2C found with the 2D-
PAGE analysis [36] (Table 2). Müller cells labeled for tubulin
β-2C can often be seen extending beyond the outer limiting
membrane  and  into  the  subretinal  space  following  retinal
detachment (Figure 5B arrow).
Labeling for α-enolase in the sham retina showed the
ganglion cell layer (GCL) and Müller cell endfeet region most
strongly labeled (Figure 4C, Figure 5C arrows) with weaker
intensity elsewhere in the retina. In the detached retina, we
found  overall  increased  labeling  with  the  Müller  cells
becoming the most noticeably labeled (Figure 4D).
Antibodies  directed  against  ATP  synthase  subunit  β
predominantly labeled Müller cells, the inner segments of
photoreceptors with labeling throughout in the sham retina
(Figure  4E,  Figure  5E).  In  the  detached  retina  we  found
decreased overall ATP synthase subunit β labeling (Figure 4F,
Figure  5F)  with  the  exception  of  the  Müller  cells,  which
remained strongly labeled (Figure 5F arrows).
Albumin labeling of the sham retina was especially high
in most cell bodies in the GCL, INL, and in processes in the
TABLE 2. MASS SPECTROMETRIC  IDENTIFICATION      OF   THE    2D-PAGE PROTEIN   SPOTS   DIFFERENTIALLY   EXPRESSED   IN  THE RABBIT RETINA.
Spot number
Protein name/Swiss-Prot
entry (Full chain length)
Theoretical
pI;Mr kDa
Fold change
RD: Sham Biological processes
1204 α-enolase (434)
ENOA_BOVIN, fragment
6.99;47.0 2.24 Glycolysis; Plasminogen activation;
Transcription; Transcription regulation
2204/2102/1102 ENOA_MOUSE, fragment 6.99;47.0 2.28/2.41/2.42
0502 Vimentin (466)
VIME_HUMAN
5.06;53.5 2.51 Cell motion
3105/3102/3502 Albumin (608)
ALBU_RABIT, N-terminal
fragment
5.67;66.5 2.66/2.95/3.19 Transport; Cellular response to starvation;
Maintenance of mitochondrial location;
Negative regulation of apoptosis; Hemolysis of
symbiont of host erythrocytes
3301 Prohibitin (272)
PHB_HUMAN
5.57;29.8 2.72 Negative regulation of cell proliferation;
Negative regulation of transcription;
Regulation of apoptosis; Signal transduction;
Histone deacetylation
9401 Fructose-bisphosphate
aldolase A (364)
ALDOA_RABIT
8.39;39.3 0.49 ATP biosynthetic process; Fructose 1,6-
bisphosphate metabolic process; Regulation of
cell shape; Actin filament organization;
Striated muscle contraction; Muscle
maintenance
1305 Transducin-β1 (340)
GBB1_HUMAN
5.60;37.2 0.48 Hormone-mediated signaling; Muscarinic
acetylcholine receptor signaling; Signal
transduction; Ras protein signal transduction
1606 ATP synthase subunit β,
mitochondrial (528)
ATPB_BOVIN
5.00;51.8 0.41 Protein transport; ATP synthesis coupled
protein transport; Regulation of intracellular
pH; Angiogenesis
8502/8503 Creatine kinase,
ubiquitous
mitochondrial (416)
KCRU_BOVIN
7.31;43.1 0.38/0.35 Creatine metabolic process
1605 Tubulin β-2C chain (447)
TBB2C_HUMAN
4.79;49.8 0.18 Cell motion; Microtubule-based movement;
Natural killer cell mediated cytotoxicity;
Protein polymerisation
         Protein spots 5101, 5703, and 8605 with fold changes of 0.48, 0.43, and 0.38 respectively could not be identified. Biological
         processes were taken from the Gene Ontology Consortium. Abbreviation: RD represents retinal detachment.
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interphotoreceptor matrix (IPM) were labeled weakly but the
photoreceptors  showed  little  or  no  labeling  (Figure  4G).
Albumin labeling showed a prominent increase in intensity
within the detached inner retina (Figure 4H, Figure 5H). At
this  resolution,  albumin  appears  in  the  Müller  cells
(colocalized  with  vimentin)  and  other  retinal  cell  types
(Figure 4H).
The control experiments showed no specific labeling and
the images were essentially black (data not shown).
DISCUSSION
In this study we undertook a comparative proteomic analysis
to elucidate proteins whose expression is influenced by retinal
detachment. The proteins identified are involved in a wide
variety of processes, including cell metabolism, cell structure,
mitochondrial  function,  and  phototransduction,  some  of
which could be used as biomarkers and therapeutic targets.
Cytoskeletal proteins:  The  expression  of  vimentin  and
tubulin β-2C were found to be significantly changed in the
retina following detachment. Vimentin was shown to increase
overall on 2D-PAGE analysis, with immunocytochemistry
confirming this to be primarily within the Müller cells [12].
Although immunocytochemistry of detached retina showed
an increase in tubulin β-2C labeling in the largely surviving
inner retina and Müller cells, 2D-PAGE analysis showed an
overall decrease in retinal tubulin β-2C following detachment.
Figure 2. Western blot analysis of sham rabbit retina developed with
anti-albumin and anti-α-enolase. The labeled arrows relate to the
respective full length proteins. Unlabeled arrows may indicate the
specific  cleavage  fragments,  and  judging  by  the  approximate
molecular mass it appears that some of these weaker bands may
correspond with the differentially expressed 2D-PAGE protein spots.
Abbreviation: MBP-1 represents Myc-binding protein-1.
This overall loss of tubulin β-2C is in agreement with previous
reports and is likely attributable to the extensive degeneration
and loss of the photoreceptor layer [36]. Indeed, the rabbit
retina shows a particularly rapid degeneration of the ONL and
outer  plexiform  layer  (OPL)  following  detachment  in
comparison to other species, which may in part be due to the
lack  of  intraretinal  vasculature  [26,37-39].  Beta-tubulin,
vimentin,  and  glial  fibrillary  acidic  protein  (GFAP)  may
structurally reinforce the endfeet region of Müller cells and
are upregulated throughout this cell type following retinal
detachment and other forms of injury [36,40]. Indeed, in mice
lacking GFAP and vimentin, the endfeet layer of the Müller
cells can easily separate from the rest of the retina following
manipulations  such  as  enucleation  and  retinal  detachment
[40,41]. Moreover, the Müller cells in these mice show an
altered response to detachment and are unable to hypertrophy
outside the retina, reinforcing the view that the intermediate
filament proteins structurally support their growth. If Müller
cell  processes  extend  into  the  subretinal  space  forming
subretinal  membranes  they  can  impede  photoreceptor
regeneration  even  after  successful  retinal  reattachment
surgery [18]. Reattachment can stop the continued growth of
Müller cell processes into the subretinal space, although they
are then induced to grow onto the vitreal retinal surface [42].
Proteins   primarily   involved   in   glycolysis: Four fragments
of α-enolase were found to be upregulated following retinal
detachment. Western blotting also revealed multiple discreet
bands, of which those at the lower molecular mass probably
correspond with the 2D-PAGE spots. This rise in α-enolase
fragmentation observed at multiple 2D-gel locations may be
indicative  of  extensive  post-translational  modification,
possibly in keeping with the multifunctional nature of this
protein that extends beyond glycolysis [43], an increased level
of protein degradation, and/or increased synthesis of the full
length protein.
Retinal detachment leads to intraretinal hypoxia [44],
which may be especially pronounced in the predominantly
avascular  rabbit  retina  [39].  This  oxygen  deprived
environment may have caused an increased expression of α-
enolase following detachment, in an effort to obtain more
energy  through  glycolysis  [45].  Indeed,  α-enolase  is  an
abundant  cytosolic  enzyme  in  many  cell  types  where  it
catalyzes  the  interconversion  of  2-phosphoglycerate  to
phosphoenolpyruvate as part of the glycolytic pathway [46].
Hypoxic-induced upregulation of α-enolase is likely to be
significantly mediated by the key regulatory protein hypoxia-
inducible factor (HIF)-1, which has a crucial role in several
oxygen-dependent diseases of the retina [47,48]. Indeed, in
addition  to  α-enolase,  HIF-1  is  able  to  activate  the
transcription of genes encoding vascular endothelial growth
factor, erythropoietin, and other glycolyic enzymes, including
fructose-bisphosphate aldolase A, which was also found to be
differentially expressed in the present study (discussed below)
[47,49-51].
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2639Müller cells have been found to be more resilient to the
effects  of  ischemia  and  hypoglycaemia  in  comparison  to
neuronal  cells,  probably  as  a  consequence  of  their  high
glycogen reserves and unusual preference for glycolysis as the
principle source of their energy even under normal aerobic
conditions [52,53]. Immunocytochemistry of the sham retina
demonstrated  particularly  high  α-enolase  labeling  of  the
Müller cell endfeet. This region, which is well known for its
significant K+ conductance [54], is also postulated to be the
origin of the intermediate filament response [27], a factor that
may  be  associated  with  the  possible  accumulation  of  α-
Figure 3. Western blot analysis of rabbit
retinas  developed  with  anti-ATP
synthase  subunit  β.  The  histogram
shows  the  mean  densitometry  of  the
antibody-antigen  reaction.  Mann–
Whitney  U  test  showed  a  significant
decrease in the levels of ATP synthase
subunit β with RD. Abbreviations: RD
represents  retinal  detachment,  Sh
represents sham.
Figure 4. Laser scanning confocal images of sham (A, C, E, G) and detached (B, D, F, H) rabbit retina labeled with antibodies for vimentin
(A-H, green), tubulin β-2C (A, B), α-enolase (C, D), ATP synthase (E, F), and albumin (G, H) all in red. Colocalization of the respective
proteins in the Müller cells is suggested by greenish yellow to yellow color. Abbreviations: OS represents outer segments; ONL represents
outer nuclear layer; INL represents inner nuclear layer; GCL represents ganglion cell layer; SRS represents subretinal space. Scale bar 20 µm.
Molecular Vision 2011; 17:2634-2648 <http://www.molvis.org/molvis/v17/a285> © 2011 Molecular Vision
2640enolase that was observed within the Müller cells following
retinal detachment in the present study.
Alpha-enolase has also been localized to the cell surface
where  it  serves  as  a  major  receptor  for  plasminogen,
facilitating its activation [55]. Aside from fibrinolysis, the
plasminogen activators and plasmin system play a role in
ECM degradation [56], and are involved in the regulation of
matrix  metalloproteinases  [57],  ECM  associated  growth
factors [58], and cell migration [59].
The α-enolase transcript encodes the α-enolase protein
with a predicted molecular mass of 47 kDa. However, with
the use of a downstream alternative start codon, the α-enolase
Figure  5.  Laser  scanning  confocal
images  of  sham  (A,  C,  E,  G)  and
detached  (B,  D,  F,  H)  rabbit  retina
labeled with antibodies for tubulin β-2C
(A, B), α-enolase (C, D), ATP synthase
β (E, F), and albumin (G, H) all in red.
Müller  cells  are  often  observed
extending  into  the  subretinal  space
following  retinal  detachment  (B,
arrow).  Labeling  for  α-enolase  was
concentrated in the Müller cell endfeet
region in sham retina, which is possibly
redistributed  within  this  cell  type
following  retinal  detachment  (C,  D,
arrows).  The  Müller  cells  remained
relatively  brightly  labeled  for  ATP
synthase  subunit  β  following  retinal
detachment  (F,  arrows).  Variable
albumin labeling of the ganglion cells
was  observed  in  sham  retina  (G,
arrows).  The  albumin  labeling  that
occurred intracellularly was shown to
increase  in  intensity  following  retinal
detachment (G, H). Abbreviations: OS
represents  outer  segments;  ONL
represents  outer  nuclear  layer;  INL
represents  inner  nuclear  layer;  GCL
represents  ganglion  cell  layer;  SRS
represents subretinal space. Scale bar 20
µm.
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2641transcript can be translated into a 37 kDa Myc-binding protein
(MBP)-1, which is predominantly localized to the cell nucleus
[43,60]. Indeed, the mass spectrometric sequences of all the
peptides analyzed were located in the MBP-1 region and we,
therefore,  cannot  differentiate  the  identified  protein  as  α-
enolase or MBP-1 (Appendix 1,Figure 2). Nuclear located
MBP-1 is able to bind with the P2 promoter of the c-myc
protooncogene, which is an important regulator of apoptosis,
cell proliferation, and differentiation [60,61], and thus could
play a role in regulating the extensive cellular remodeling that
occurs after retinal detachment.
One 2D-gel spot was identified as fructose-bisphosphate
aldolase A, a glycoltyic enzyme that catalyzes the conversion
of fructose 1,6-bisphosphate into glyceraldehyde 3-phosphate
and dihydroxyacetone phosphate. The amount of aldolase A
appeared  to  diminish  in  the  retina  following  retinal
detachment, which may be secondary to the photoreceptor cell
loss observed, increased degradation, or a decrease in protein
synthesis. The changes in expression could also be related to
the ability of aldolase A to influence retinal cell structure and
motility through its known binding interactions with the actin
component of the cytoskeleton [62-64]. Indeed, the levels of
actin in the retina have been shown to decrease following
retinal detachment, possibly contributing to destabilization of
photoreceptor  structure,  including  outer  segment
degeneration [36].
Mitochondrial  proteins:  The  retina  is  an    extremely
metabolically active tissue [65,66], with the photoreceptors
among the most energetic cells in the body [67]. We observed
decreased  levels  of  the  two  mitochondrial  proteins,  ATP
synthase β and creatine kinase with retinal detachment. These
findings are likely to be associated with a decreased need for
energy metabolism, and/or the disruption of the photoreceptor
ellipsoid region and mitochondria loss known to occur as a
consequence of photoreceptor degeneration following retinal
detachment [27].
The catalytic activity to produce ATP from ADP and
inorganic phosphate by way of a proton gradient is located on
the  β  subunit  of  mitochondrial  ATP  synthase  [68].
Immunocytochemical studies of ATP synthase β within the
sham  retina  showed  especially  high  labeling  in  the
mitochondrial rich Müller cells and the inner segments of the
photoreceptors  [69-71].  Following  retinal  detachment,  the
Müller cells continued to be brightly labeled, especially in the
inner  half  of  the  retina,  while  the  photoreceptor  inner
segments and remaining retina showed a decreased signal.
Indeed, the loss of mitochondria from their major localization
in the inner segments of the photoreceptors and also their
synaptic endings in the OPL due to retinal detachment has
been shown to be preventable by simple hyperoxia treatment
[71]. The dysfunction and loss of mitochondria are likely to
have  profound  effects  on  the  ability  of  the  highly  active
photoreceptors to regenerate, despite surgical reattachment of
the retina [5].
Mitochondrial creatine kinase (MtCK) was found to be
reduced after retinal detachment at two closely positioned 2D-
PAGE  spots,  largely  in  accordance  with  the  predicted
molecular  mass.  Creatine  kinase  reversibly  catalyzes  the
phosphorylation  of  creatine  with  the  use  of  ATP.  The
phosphocreatine reservoir that is formed plays a crucial role
in cellular ATP buffering and transport, particularly in cells
with high and fluctuating energy needs such as those present
in  the  retina  [72,73].  MtCK  is  also  able  to  prevent  the
formation of reactive oxygen species (ROS) [74], and by
directly inhibiting the permeability of the mitochondrial outer
membrane it can help to avert mitochondrial metabolic failure
[75,76]. Indeed, mitochondrial failure can directly lead to cell
necrosis, or by the release of appropriate factors, can trigger
apoptosis [77-79]. The degeneration and subsequent death of
photoreceptors  following  retinal  detachment  is  known  to
occur mainly by apoptosis, with necrosis playing a smaller
role [5,80].
Albumin:  Three  2D-gel  spots  identified  as  fragments of
albumin  were  found  to  increase  with  retinal  detachment.
Increased protein fragmentation suggests that higher levels of
proteolytic cleavage occur in detached retina. Indeed, albumin
degradation is known to occur in tissues throughout the body
[81].  Using  immunocytochemistry,  we  demonstrated
intracellular albumin within most retinal cell types, mainly
confined to the inner retina, which increased in intensity with
detachment. The source of albumin within the retinal cells is
unclear, however, the cellular internalization of albumin is
believed to involve a receptor-mediated process [82-84]. It is
widely believed that albumin and other proteins from the
vitreous can enter the subretinal space through a retinal break,
where they become concentrated as water and small molecules
are  absorbed  across  the  RPE  [85].  Indeed,  pathological
subretinal  fluid  following  retinal  detachment  has  a  very
different protein composition from normal IPM, containing
significant  amounts  of  serum  proteins  such  as  albumin,
transferrin, and gammaglobulin subunits [86]. Albumin may
also originate from the retinal vasculature, the rate of which
may presumably be increased by transport mechanisms or
following RPE damage [87]. However, no blood was noted
during the detachment surgery or tissue harvesting that would
indicate damage to the RPE-choroid complex or the blood
vessels of the rabbit retina, which is predominantly avascular
apart from a band of retinal vessels on either side of the optic
disc [26,39]. Nevertheless, it is well known that the integrity
of the blood-ocular barrier can be compromised due to the
physical  and  metabolic  effects  of  retinal  detachment  [3,
88-90].  It  should  also  be  considered  that  although  it  is
generally presumed that the liver is the main, if not sole,
source of albumin synthesis, extrahepatic production sites
such  as  the  brain  have  been  suggested  [91,92].  It  may,
therefore, be possible that the increased presence of albumin
fragments  observed  in  the  present  study  could  also  be
explained by de novo synthesis.
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2642Albumin is the most abundant vitreal and plasma protein,
where in the latter it is known to function as the key regulator
of the colloidal osmotic pressure of blood and as a major
transport protein for many important metabolic molecules
[81,93,94]. Indeed, vitreal albumin has been suggested to
facilitate the transport of long chain fatty acids into the lens
for the synthesis of lens lipids [93]. This versatile protein also
possesses  anti-inflammatory  and  apoptotic  regulatory
properties,  and  is  able  to  maintain  redox  potentials  by
scavenging  ROS  and  sequestering  redox  active  transition
metal  ions  [81,95-97].  It  may  be  possible  that  increased
albumin within the retina could result from local synthesis as
a  protective  response  to  the  oxidative  stress  produced  by
retinal detachment [98,99], in a manner similar to that which
has been proposed for glaucoma [100]. Since albumin has also
been localized to the IPM of the retinas of humans and other
vertebrate species in accordance with our observations, and
has been shown to have the ability to bind with retinoids, it
has  been  postulated  that  albumin  could  contribute  to  the
transport  of  visual  cycle  molecules,  alike  to
interphotoreceptor retinoid-binding protein [91,101]. Indeed,
the role of albumin in healthy and detached retina may be as
significant and diverse as its known functions throughout the
body, though this remains to be characterized.
Prohibitin 1:   2D-PAGE  analysis  showed  prohibitin 1  to
be  upregulated  following  retinal  detachment.  Prohibitin  1
forms a physiologically active structure by complexing with
the closely related protein prohibitin 2 (prohibitone) [102].
These poorly understood proteins are ubiquitously expressed
in a wide range of organisms and have been localized to the
mitochondrial  membrane,  and  more  recently  to  the  cell
nucleus  and  plasma  membrane  [103].  The  prohibitins  are
postulated to stabilize newly synthesized respiratory chain
proteins,  maintain  mitochondrial  structure,  repress
transcription  and  cell  cycle  progression,  and  regulate
apoptosis [102,104-108]. These proteins have been associated
with  certain  pathological  states,  including  inflammation
[109] and cancer [110], and may well play an important role
in cellular processes following retinal detachment.
Transducin-β1: The  level  of  rod  transducin-β1 subunit
was  shown  to  decrease  following  retinal  detachment.
Transducin is a heterotrimeric (α- β- and γ-subunit) guanine
nucleotide-binding  protein  that  is  coupled  as  different
isoforms  with  rod  and  cone  opsin,  and  functions  in  the
phototransduction  cascade  [111,112].  Excessive
phototransduction  signaling  and  dysfunctional  protein
trafficking  involving  transducin  has  been  implicated  as
potentiating  factors  of  photoreceptor  apoptosis  in  light-
induced and inherited retinal degenerations [112-114]. In the
present study, however, the downregulation of rod transducin-
β1 is likely a reflection of the generalized photoreceptor cell
degeneration that was observed in the rod-dominated rabbit
retina following detachment [26,37,38].
Conclusions:  The  differentially  expressed  proteins
elucidated in this study may play an important role in the
cellular  responses  of  the  retina  after  its  detachment,
subsequent ability to recover following surgical reattachment,
as well as in serious complications such as subretinal fibrosis
and  PVR.  Further  investigations  of  these  proteins  are
necessary to determine their functions, and to establish their
use as potential biomarkers and therapeutic targets.
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2647Appendix  1.  Mass  spectrometric  identification,  including  sequence
information, of the 2D-PAGE protein spots differentially expressed in the
rabbit retina.
Protein spots 5101, 5703, and 8605 with fold changes of
0.48,  0.43,  and  0.38  respectively  could  not  be  identified.
Individual Mascot ions scores greater than approximately 36
indicate identity or extensive homology (p<0.05). Biological
processes were taken from the Gene Ontology Consortium.
Abbreviation: RD represents retinal detachment. To access
the data, click or select the words “Appendix 1.” This will
initiate  the  download  of  a  compressed  (pdf)  archive  that
contains the file.
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